Synco Bio Partners Enters The Japanese Market As It Signs Its First Agreement With A Japanese Pharma
                    
                    
                        



  
                        1st September 2009 - 
                        Views: 839                    
                                        SynCo Bio Partners B.V., the expert in long term GMP contract  manufacturing of biopharmaceuticals announced today that it has expanded its  business into a new geographical market, with the signing of a contract to  manufacture a live biotherapeutic for an emerging Japanese pharmaceutical  company.
                
                    
                        Dementia Report An Urgent Reminder To Act - Acsa
                    
                    
                        



  
                        1st September 2009 - 
                        Views: 893                    
                    
                    Aged and Community Services Australia (ACSA) has applauded the release of the Access Economics  report – Keeping Dementia Front of Mind: Incidence and Preval ence 2009 –  2050 – commissioned by  Alzheimer’s Australia.
                
                    
                        New Results In Angina Patients: Fewer Heart Attacks With Procoralan(r) (ivabradine)*
                    
                    
                        



  
                        1st September 2009 - 
                        Views: 869                    
                                        Important new findings in patients with angina participating in the  BEAUTIFUL study show that there is a 42% reduction in heart attack with  Procoralan(R) (ivabradine)*, as presented today at the European Society of  Cardiology (ESC) Congress.
                
                    
                        Crestor(r) Reduced The Risk Of Cardiovascular Events In Elderly Patients In New Analysis Of Jupiter
                    
                    
                        



  
                        1st September 2009 - 
                        Views: 918                    
                                        These results are consistent with the CV risk reduction seen across all patients taking rosuvastatin in the primary JUPITER
analysis. This new analysis was presented today at the European Society of Cardiology (ESC) meeting in Barcelona, Spain.
                
                    
                        The Confederation Of Meningitis Organisations (como) Applauds The Actions Of The Government Of Hong
                    
                    
                        



  
                        31st August 2009 - 
                        Views: 863                    
                                        "The inclusion of the vaccine to the childhood immunisation program is a significant milestone for Hong Kong  and its children," said Mr Langoulant.